key: cord-0745497-4ygove6v
authors: Sánchez‐Montes, Sokani; Ballados‐González, Gerardo G.; Gamboa‐Prieto, Janete; Cruz‐Romero, Anabel; Romero‐Salas, Dora; Pérez‐Brígido, Carlos D.; Austria‐Ruíz, María J.; Guerrero‐Reyes, Alfredo; Lammoglia‐Villagómez, Miguel A.; Camacho‐Peralta, Ireri P.; Morales‐Narcia, José Á.; Bravo‐Ramos, José L.; Barrientos‐Villeda, Manuel; Blanco‐Velasco, Leopoldo A.; Becker, Ingeborg
title: No molecular evidence of SARS‐CoV‐2 infection in companion animals from Veracruz, Mexico
date: 2021-06-02
journal: Transbound Emerg Dis
DOI: 10.1111/tbed.14153
sha: f76cec4d38d844049cc9166f901635f191513c42
doc_id: 745497
cord_uid: 4ygove6v

Active epidemiological surveillance of infectious agents represents a fundamental tool for understanding the transmission dynamics of pathogens and establishing public policies that can reduce or limit their expansion. Epidemiological surveillance of emerging agents, such as the recently recognized severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the cause of COVID‐19, is essential to establish the risk of transmission between species. Recent studies reveal that companion animals are organisms susceptible to being infected by this pathogen due to the close contact they have with their owners. For this reason, the aim of the present work was to detect the presence of SARS‐CoV‐2 in dogs and cats in the state of Veracruz, Mexico, where there is active transmission of this microorganism in human populations. Oral and nasopharyngeal swab samples were collected from dogs and cats with a history of exposure to patients with COVID‐19. Total RNA was extracted and detection of viral genes N1 and N2 was performed by reverse transcription polymerase chain reaction (RT‐qPCR). All 130 samples of companion animals tested by RT‐qPCR for SARS‐CoV‐2 were negative at the time they were collected. This study represents the second active surveillance of SARS‐CoV‐2 in populations of domestic dogs and cats in Latin America and the first approach in Mexico. Given that coronaviruses have shown a high capacity to be transmitted between species, it is imperative to establish measures to prevent this agent from entering and establishing in populations of companion animals.

case of COVID-19 was recorded in Mexico City; however, community transmission was not recognized in the country until 24 March 2020 (DGE, 2020). Since then, 1,313,675 confirmed cases have been registered, with a cumulative incidence rate of 1,037.84 cases per 100,000 inhabitants until week 51 of the current year (DGE, 2020) .

In recent months, a potential process of reverse transmission of SARS-CoV-2 from humans to other species has been raised globally, for which the need to implement active epidemiological surveillance in other species, particularly those that have a close contact with humans, such as cats and dogs, has become imperative (Newman et al., 2020) . Experimental studies have revealed that SARS-CoV-2 has a low replicative potential in dogs; however, cats are permissive to be infected through airway transmission .

Additionally, in silico studies support the susceptibility of felines to this infectious agent (Martínez-Hernández et al., 2020) . Reports of naturally infected companion animals have emerged from six countries in Europe, two from America and one from Asia (Table 1 ). In these countries, a prevalence that fluctuates between 0% and 17.65% for cats and 0% and 13.33% for dogs, has been recorded, depending on the detection method implemented (serology and/or molecular methods) ( Table 1) .

Most of the reports originate from animals without clinical signs; however, in four case studies carried out in cats, the presence of respiratory symptoms of varying severity, accompanied by lethargy and/or pyrexia, has been reported Garigliany et al., 2020) . In the case of dogs, there is a worldwide debate regarding their susceptibility because there are no clear clinical signs suspicious for the condition; thus, the possible impact that this viral agent may have on dog populations remains unknown (Segalés et al., 2020; Sit et al., 2020) . These data highlight the necessity to improve an active surveillance study of the circulation of SARS-CoV-2 in companion animals in Mexico.

In the state of Veracruz, there have been 41,816 cases of COVID-19 with an accumulative incidence rate of 492.62 cases per 100,000 inhabitants until week 51 of 2020 (DGE, 2020) . The aim of this work was to monitor SARS-CoV-2 in companion animals in close contact with human patients with SARS-CoV-2 in Veracruz, one of the states with active transmission of COVID-19 in Mexico. A cross-sectional, observational epidemiological study was carried out in five municipalities of the state of Veracruz with active transmission of SARS-CoV-2 in human populations. To improve that, an intentional search was conducted for cats and dogs of owners having a confirmed diagnosis of COVID-19 (breathing and/ or digestive symptoms, positive rapid test (exclusively viral antigen detection) and/or positive polymerase chain reaction test) 2 weeks prior to sampling. In addition, demographic data of companion animals (sex and age) were collected.

Dogs were physically restrained and cats were sedated with an intramuscular injection of ketamine and xylazine (Wildlife Pharmaceutics Mexico, Mexico City, Mexico). Nasal and/or oral swab samples were collected and fixed in 1.5 ml of Trizol Reagent (Invitrogen, California, USA) for inactivation of the virus and preservation of the viral RNA (Fernández-Figueroa et al., 2016) . Afterwards, the samples were preserved in a cold chain until their extraction in the laboratory. 1 ml of the sample was transferred to a conical 1.5ml plastic tube, after which 200 μl of cold chloroform was added (Sigma). This solution was mixed and centrifuged at 19,357× g for 10 min at 4°C. The aqueous phase was recovered and 500 μl of cold isopropanol was added (Sigma). The resulting solution was mixed for 15 s and incubated overnight at −20°C. Thereafter, the solution was centrifuged at 19,357× g for 10 min at 4°C. The supernatant was discarded and 1 ml ethanol 80% (Sigma) was added, the solution was mixed for 10 s and centrifuged at 19,357× g for 10 min at 4°C. The ethanol was discarded, the excess was air-dried, and the pellet was suspended in 40 µl RNase free water. The total RNA was quantified using a NanoDrop 2000/2000c spectrophotometer (Thermo Fisher Scientific, Massachusetts, USA) and subsequently adjusted to an average concentration of 5 ng. The extracted RNA samples were subjected to cDNA synthesis using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, California, USA). To confirm the presence and integrity of the extracted RNA, dog-specific cytochrome oxidase subunit 1 (COX-1) amplification was performed (Sales et al., 2020) . In the case of cats, after cDNA synthesis, to check the RNA quality, PCR was performed for the endogenous control, COX-1, by conventional PCR (cPCR) using the primers and conditions of Hafner et al. (1994) . Otatitlan, Papantla and Texistepec only registered a single sample each (Table 2) .

Regarding sex, in the case of canines, 63 samples were collected from males and 37 from females, while in the case of felines, samples were taken from 13 males and 17 females. The ages of the sampled animals ranged from one month to 14 years, with an average of 5 years (Table 2) .

RNA quality was evaluated by the amplification of the endogenous COX-1 gene from all tested samples. All 139 samples of companion animals tested by RT-qPCR for SARS-CoV-2 were negative at the time they were collected. Garigliany et al., 2020; Hamer et al. 2020 ). In the case of dogs, the only record from the USA that reports exposure time from the owner's confirmation positive for COVID-19 and the positive test of the animal was seven days (Hamer et al., 2020) 

Italy where samples were collected from dogs and cats with owners confirmed with COVID-19, 15 days before taking the sample, presented similar results to those of our study, where all the samples were negative (Patterson et al., 2020) . It is important to mention that The reports in which the presence of SARS-CoV-2 has been detected in cats and dogs show that close contact between infected humans poses a risk to companion animals Garigliany et al., 2020; Segalés et al., 2020) . Particularly, Brazil was the first country in Latin America to report the sequencing of the complete SARS-COV-2 genome from a cat infected by its owner (Carlos et al., 2021) .

For this reason, the need to limit contact between human patients, with a presumptive or confirmatory diagnosis of COVID-19, and their companion animals is reiterated, in an effort to avoid infecting these companion species through airborne transmissions. Historically, it has been documented that humans can infect companion animals with other infectious agents, such as tuberculosis in companion dogs (Erwin et al., 2004; Hackendahl et al., 2004) .

Given that coronaviruses have shown a high capacity to be transmitted between species, it is imperative to establish measures to prevent this agent from entering and establishing in populations of companion animals (Contini et al., 2020; Martínez-Hernández et al., 2020) . Additionally, it is essential for owners to remember that pets are not a source of SARS-CoV-2 infection for humans, so their safety and integrity must be preserved, and owners should avoid abandoning them. The participation of veterinarians in the surveillance of this emerging agent is essential, which will guide health policies to safeguard the health and well-being of companion animals during this global emergency.

We thank the dog and cat owners who decided to participate in this project. We also thank David Reyes-Córdova for field assistance. The project was financed by CONACYT 312224 'COVID-19

en México: epidemiología de la enfermedad en población mexicana con énfasis en pacientes oncológicos e identificación de animales de compañía como unidades centinela para detectar SARS-CoV-2'.

The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest, nonfinancial interest in the subject matter or materials discussed in this manuscript.

The authors confirm that the ethical policies of the journal, as noted on the journal's author guidelines page, have been adhered to. 

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Sokani Sánchez-Montes https://orcid.org/0000-0001-6316-2187

Anabel Cruz-Romero https://orcid.org/0000-0003-4080-6722

Ingeborg Becker https://orcid.org/0000-0003-3821-4998

SARS-CoV-2 in quarantined domestic cats from COVID-19 households or close contacts

First genome sequencing of SARS-CoV-2 recovered from an infected cat and its owner in Latin America

The novel zoonotic COVID-19 pandemic: An expected global health concern

Boletín Epidemiológico Sistema Nacional de Vigilancia Epidemiológica Sistema Único de Información. Boletín Epidemiológico

Mycobacterium tuberculosis transmission from human to canine

Down-Regulation of TLR and JAK/STAT Pathway Genes Is Associated with Diffuse Cutaneous Leishmaniasis: A Gene Expression Analysis in NK Cells from Patients Infected with Leishmania mexicana

SARS-CoV-2 natural transmission from human to cat

Putative transmission of Mycobacterium tuberculosis infection from a human to a dog

Disparate rates of molecular evolution in cospeciating hosts and parasites

Natural SARS-CoV-2 infections, including virus isolation, among serially tested cats and dogs in households with confirmed human COVID-19 cases in Texas

Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals. Vaccines

Assessing the SARS-CoV-2 threat to wildlife: Potential risk to a broad range of mammals

Occurrence of antibodies against SARS-CoV-2 in the domestic cat population of Germany. Vaccines, 8, 772

New SARS-CoV-2 infection detected in an Italian pet cat by RT-qPCR from deep Pharyngeal Swab. Pathogens, 9

A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners

First reported cases of SARS-CoV-2 infection in companion animals

Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy

Detection of SARS-CoV-2 in pets living with COVID-19 owners diagnosed during the COVID-19 lockdown in Spain: A case of an asymptomatic cat with SARS-CoV-2 in Europe

First detection and genome sequencing of SARS-CoV-2 in an infected cat in France

Fast multiplex real-time PCR assay for simultaneous detection of dog and human blood and Leishmania parasites in sand flies

Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2

Canine SARS-CoV-2 infection

Seroprevalence of SARS-CoV-2 infection among pet animals in Croatia and potential public health impact. Transboundary and Emerging Diseases

Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus

A serological survey of SARS-CoV-2 in cat in Wuhan

No molecular evidence of SARS-CoV-2 infection in companion animals from